Abstract: The invention relates to a method for producing a catalyst, wherein the catalyst has a high activity and selectivity with regard to the oxidation of CO and NO. The invention also relates to the catalyst produced using the method according to the invention, the use of the catalyst as oxidation catalyst as well as a catalyst component which contains the catalyst according to the invention. Finally, the invention is directed towards an exhaust-gas cleaning system which comprises the catalyst component containing the catalyst according to the invention.

Abstract: The present invention relates to novel thienopyrimidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

Abstract: An apparatus for listening room equalization is provided. A system identification adaptation unit is configured to adapt a first loudspeaker-enclosure-microphone system identification to obtain a second loudspeaker-enclosure-microphone system identification. A filter adaptation unit is configured to adapt a filter based on the second loudspeaker-enclosure-microphone system identification a predetermined loudspeaker-enclosure-microphone system identification. A filter includes a plurality of subfilters each of which receive one or more of the transformed loudspeaker signals. Each of the subfilters is adapted to generate one of a plurality of filtered loudspeaker signals based on the one or more received loudspeaker signals. At least one of the subfilters is arranged to couple the at least two received loudspeaker signals to generate one of the plurality of the filtered loudspeaker signals.

Abstract: The present invention relates to novel thienopyrimidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

Abstract: A solid catalyst component comprising the product of a process comprising (a) reacting a magnesium alcoholate of formula Mg(OR1)(OR2) compound, in which R1 and R2 are identical or different and are each an alkyl radical having 1 to 10 carbon atoms, with titanium tetrachloride carried out in a hydrocarbon at a temperature of 50-100° C., (b) subjecting the reaction mixture obtained in (a) to a heat treatment at a temperature of 110° C. to 200° C. for a time ranging from 3 to 25 hours (c) isolating and washing with a hydrocarbon the solid obtained in (b), said solid catalyst component having a Cl/Ti molar ratio higher than 2.5.

Abstract: A redundantly operated industrial communication system includes communication devices that are redundantly linked to an industrial communication network and includes network infrastructure devices associated with the industrial communication network, wherein message transmission occurs wirelessly at least in sections. The industrial communication network contains a plurality of buffer memory units for message elements that are received at a network node by wire and message elements that are to be sent by the network node wirelessly. When a maximum buffer size is exceeded, an oldest message element situated in a respective buffer memory unit is erased. Until the maximum buffer size is exceeded, the oldest message element is selected as the next message element to be sent wirelessly.

Abstract: The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

Abstract: A tube of a surgical microscope has a base part, intermediate part pivotable about a rotational axis on the base part, and an ocular part pivotable about a rotational axis on the intermediate part. An imaging beam path passes through the base part, intermediate part and ocular part. The tube has a tube lens system which transfers a parallel imaging beam path into an intermediate image. The parallel imaging beam path enters via an opening in a connecting piece of the base part. The tube has a first mirror movable about the rotational axis on the base part and a further mirror movable on the intermediate part about the rotational axis. The first mirror directs the imaging beam path to the further mirror. The first mirror and further mirror are mounted in the imaging beam path between a lens unit having positive refractive power and a lens unit having negative refractive power.

Abstract: The present invention relates to a catalytic composition comprising a noble metal on an acidic tungsten-containing mixed oxide, a method for producing the catalytic composition and the use of the catalytic composition as oxidation catalyst. The invention further relates to a catalyst shaped body, which has the catalytic composition on a support, a washcoat containing the catalytic composition according to the invention and the use of the washcoat to produce a coated catalyst shaped body.

Abstract: Provided are new partially hydrogenated nitrile rubbers which are distinguished by a specific ratio of viscosity to molecular weight, and also vulcanizable mixtures and vulcanizates based on said rubbers, and also the associated preparation processes. The partially hydrogenated nitrile rubbers lead to compounded formulations having advantageous processing properties in conjunction with excellent vulcanizate properties.

Abstract: A catalyst system for the polymerization of olefins comprising (A) a catalyst component obtained by reacting a Mg(OR1)(OR2) compound, in which R1 and R2 are identical or different and are each an alkyl radical having 1 to 10 carbon atoms, with a tetravalent transition metal compound having at least a Metal-halogen bond, used in amounts such that the molar ratio Met-al/Mg is from 0.05 to 10; (B) an aluminum alkyl compound and (C) a linear or branched halogenated alkyl compound.

Abstract: An internal combustion engine including at least one cylinder, at least one in-block camshaft, at least one overhead intake valve and at least one overhead exhaust valve, as well as at least one rocker arm bracket per cylinder, the rocker arm bracket having an in particular tubular shaft on which are mounted at least one exhaust rocker arm and at least one intake rocker arm.

Abstract: The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability.

Abstract: A tube of a surgical microscope has a base part, intermediate part pivotable about a rotational axis on the base part, and an ocular part pivotable about a rotational axis on the intermediate part. The imaging beam path is guided through the base part, intermediate part and pivotable ocular part. The tube has a tube lens system which transfers a parallel imaging beam path into an intermediate image. The parallel imaging beam path enters via an opening in a connecting piece of the base part. The tube has a first displaceable mirror element movable about the rotational axis on the base part. The tube has a further displaceable mirror element movable on the intermediate part about the rotational axis. The first mirror element directs the imaging beam path to the further mirror element. The first mirror element and further mirror element are mounted in the imaging beam path between a lens unit having positive refractive power and a lens unit having negative refractive power.

Abstract: Catalysts for metathesis reactions, in particular for the metathesis of nitrile rubber, are provided.

Abstract: The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

Abstract: A device for controlling material flows may include at least one feeding device for feeding material of at least one type of material, at least one output device for outputting material of at least one type of material, a transport device for transporting the material, at least one sensor for determining at least one state-dependent parameter of the device, and a control device for controlling the devices, the control device being designed to process event-based signals, e.g., signals from the at least one sensor.

Abstract: An imaging system (1) comprises an antenna array (2), 24 GHz transceivers (3), and a digital receiver (4) including an ADC and circuits for filtering. The digital receives commands from the host PC (5) and passes data to the host PC (5) for display. The host PC 5 initiates volume scans, performs system diagnostics and error reporting, and collects scan data and displays it for the operator. The digital receiver (4) presents the scan requests to the antenna array (2) in a synchronised manner. All control signals in the antenna array are presented via a presentation clock (an individual presentation clock being generated for sub-sections of the array; of the order of five hundred presentation clocks are generated). The spectral content of each presentation clock is adjusted via a spreading circuit, thus adjusting the spectral interference radiated through the printed circuit board traces to the FET elements that each presentation clock feeds. The spreading clock generation circuit include taps (Tap 1, Tap 2 . .

Abstract: A catalyst component for the polymerization of olefins obtained by: (a) reacting in a inert hydrocarbon suspension medium a Mg(OR1)(OR2) compound, in which R1 and R2 are identical or different and are each an alkyl radical having 1 to 10 carbon atoms, with a tetravalent transition metal compound having at least a Metal-halogen bond, used in amounts such that the molar ratio metal/Mg is from 0.05 to 10, thereby obtaining a solid reaction product dispersed in a hydrocarbon slurry, (b) washing the solid reaction product dispersed in a hydrocarbon slurry with a liquid hydrocarbon, (c) contacting the washed solid reaction product obtained in (b) with a tetravalent titanium compound and (d) contacting the product obtained in (c) with an organometallic compound of a metal of group 1, 2 or 13 of the Periodic Table.

Abstract: The present invention relates to novel thienopyhmidine compounds of general formula (I), pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.